The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors
Abstract
By examining inhibitor interactions with single and multiple site-specific mutants of mouse acetylcholinesterase, we have identified three distinct domains in the cholinesterase structure that are responsible for conferring selectivity for acetyl- and butyrylcholinesterase inhibitors. The first domain is the most obvious; it defines the constraints on the acyl pocket dimensions where the side chains of F295 and F297 primarily outline this region in acetylcholinesterase. Replacement of these phenylalanine side chains with the aliphatic residues found in butyrylcholinesterase allows for the catalysis of larger substrates and accommodates butyrylcholinesterase-selective alkyl phosphates such as isoOMPA. Also, elements of substrate activation characteristic of butyrylcholinesterase are evident in the F297I mutant. Substitution of tyrosines for F295 and F297 further alters the catalytic constants. The second domain is found near the lip of the active center gorge defined by two tyrosines, Y72 and Y124, and by W286; this region appears to be critical for the selectivity of bisquaternary inhibitors, such as BW284C51. The third domain defines the site of choline binding. Herein, in addition to conserved E202 and W86, a critical tyrosine, Y337, found only in the acetylcholinesterases is responsible for sterically occluding the binding site for substituted tricyclic inhibitors such as ethopropazine. Analysis of a series of substituted acridines and phenothiazines defines the groups on the ligand and amino acid side chains in this site governing binding selectivity. Each of the three domains is defined by a cluster of aromatic residues. The two domains stabilizing the quaternary ammonium moieties each contain a negative charge, which contributes to the stabilization energy of the respective complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
[19] Rapid and efficient site-specific mutagenesis without phenotypic selection
Kunkel, T. A., Roberts, J. D., & Zakour, R. A. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)54085-x · Cited by 5,261
Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991) · Science · doi:10.1126/science.1678899 · Cited by 2,707
Enzyme and metabolic inhibitors
Webb, J. L. (1963) · Academic Press eBooks · doi:10.5962/bhl.title.7320 · Cited by 1,514
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Comparison of butyrylcholinesterase and acetylcholinesterase
Chatonnet, A., & Lockridge, O. (1989) · Biochemical Journal · doi:10.1042/bj2600625 · Cited by 549
Taylor, P., & Lappi, S. (1975) · Biochemistry · doi:10.1021/bi00680a029 · Cited by 364
Self-citationAmino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity
Vellom, D. C., Radic, Z., Li, Y., Pickering, N. A., Camp, S., & Taylor, P. (1993) · Biochemistry · doi:10.1021/bi00052a003 · Cited by 312
Self-citationConversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
Harel, M., Sussman, J. L., Krejci, E., Bon, S., Chanal, P., Massoulié, J., & Silman, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10827 · Cited by 291
Avigdor Shafferman, C., Velan, B., Ordentlich, A., Kronman, C., Grosfeld, H., Leitner, M., Flashner, Y., Cohen, S., Barak, D., & Ariel, N. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05439.x · Cited by 222
Cited by
Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,101
Neurobiology of butyrylcholinesterase
Darvesh, S., Hopkins, D. A., & Geula, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1035 · Cited by 891
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products
Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., & Nachon, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210241200 · Cited by 840
Kryger, G., Silman, I., & Sussman, J. L. (1999) · Structure · doi:10.1016/s0969-2126(99)80040-9 · Cited by 757
The Cholinesterases: From Genes to Proteins
Taylor, P., & Radic, Z. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001433 · Cited by 669
Self-citationTargeting acetylcholinesterase and butyrylcholinesterase in dementia
Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005833 · Cited by 654
Electrostatic Origin of the Catalytic Power of Enzymes and the Role of Preorganized Active Sites
Warshel, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27035 · Cited by 611
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site
Bourne, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg005 · Cited by 488
Cellular and molecular actions of Methylene Blue in the nervous system
Oz, M., Lorke, D. E., Hasan, M., & Petroianu, G. A. (2011) · Medicinal Research Reviews · doi:10.1002/med.20177 · Cited by 443
In Situ Click Chemistry: Enzyme Inhibitors Made to Their Own Specifications
Manetsch, R., Krasiński, A., Radić, Z., Raushel, J., Taylor, P., Sharpless, K. B., & Kolb, H. C. (2004) · Journal of the American Chemical Society · doi:10.1021/ja046382g · Cited by 423
Self-citationAcetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo
Behra, M., Cousin, X., Bertrand, C., Vonesch, J.-L., Biellmann, D., Chatonnet, A., & Strähle, U. (2002) · Nature Neuroscience · doi:10.1038/nn788 · Cited by 417
Harel, M., Quinn, D. M., Nair, H. K., Silman, I., & Sussman, J. L. (1996) · Journal of the American Chemical Society · doi:10.1021/ja952232h · Cited by 369
Li, B., Stribley, J. A., Ticu, A., Xie, W., Schopfer, L. M., Hammond, P., Brimijoin, S., Hinrichs, S. H., & Lockridge, O. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.751320.x · Cited by 354
Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex
Bourne, Y., Taylor, P., & Marchot, P. (1995) · Cell · doi:10.1016/0092-8674(95)90128-0 · Cited by 347
Self-citationHighly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase
Pang, Y.-P., Quiram, P., Jelacic, T., Hong, F., & Brimijoin, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23646 · Cited by 344
Krasiński, A., Radić, Z., Manetsch, R., Raushel, J., Taylor, P., Sharpless, K. B., & Kolb, H. C. (2005) · Journal of the American Chemical Society · doi:10.1021/ja043031t · Cited by 338
Self-citationFreeze-frame inhibitor captures acetylcholinesterase in a unique conformation
Bourne, Y., Kolb, H. C., Radić, Z., Sharpless, K. B., Taylor, P., & Marchot, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308206100 · Cited by 332
Self-citationJohnson, G., & Moore, S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775193127 · Cited by 321
Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis
Kang, T. S., Georgieva, D., Genov, N., Murakami, M. T., Sinha, M., Kumar, R. P., Kaur, P., Kumar, S., Dey, S., Sharma, S., et al. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08115.x · Cited by 315
Rosenberry, T. L., Brazzolotto, X., Macdonald, I. R., Wandhammer, M., Trovaslet-Leroy, M., Darvesh, S., & Nachon, F. (2017) · Molecules · doi:10.3390/molecules22122098 · Cited by 298
The Origin of the Molecular Diversity and Functional Anchoring of Cholinesterases
Massoulié, J. (2002) · Neurosignals · doi:10.1159/000065054 · Cited by 281
Amyloid–cholinesterase interactions: Implications for Alzheimer’s disease
Inestrosa, N. C., Dinamarca, M. C., & Alvarez, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06238.x · Cited by 261
Methylene blue and Alzheimer's disease
Oz, M., Lorke, D. E., & Petroianu, G. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.034 · Cited by 257
Masson, P., & Lockridge, O. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.12.005 · Cited by 233
Yetisen, A. K., Butt, H., Volpatti, L. R., Pavlichenko, I., Humar, M., Kwok, S. J. J., Koo, H., Kim, K. S., Naydenova, I., Khademhosseini, A., et al. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.005 · Cited by 192
Klegeris (1997) · doi:10.1002/(sici)1097-4547(19970715)49:2
Metadata
- Authors
- Radic, Z., Pickering, N. A., Vellom, D. C., Camp, S., & Taylor, P.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1993-11-01
- Volume
- 32
- Issue
- 45
- Pages
- 12074-12084
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2011000826
- Cited by
- 437
- References
- 22
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.